90 results about "Syringic acid" patented technology

Dry milling methods for preparing oat products enriched in the content of β-glucan and methods for preparing foodstuffs incorporating such an enriched oat product especially ready-to-eat cereals are provided. Heat conditioned dehulled oats are dry milled to form a coarse whole non defatted oat flour and then, without a preceding removal of fat, dry fractionated into coarser bran and finer oat flour fractions at multiple stages. The coarse oat flour is first dry classified to separate or form a coarser fraction oat bran containing more concentrated β-glucan and a finer oat flour or starch containing or endosperm containing fraction. The oat bran is fractionated into a coarse and fine oat bran sub-streams. The oat bran sub-streams are each is subjected to second roller milling step and then bolted. The second bolting of oat bran is then subjected to a third round of milling and classification to form a high β-glucan content (>7-9%) oat bran and a low β-glucan content (3%) oat flour. The methods are low cost and commercially practical. Preferably, the high β-glucan content oat bran and oat flour fractions can have a syringic acid to ferulic acid ratio of at least 2.5:1 indicating improved flavor. Preferably, the oat bran and oat flour have a Farinograph value of 5 to 20 minutes indicated partial gelatinization. The oat bran and oat flours can be used to prepare foodstuffs such as ready-to-eat cereals.

The present invention relates to a compound of the formula:R-AR—O—Y—R′Wherein R represents one or more members selected from H, alkoxy, benzyloxy, aldehyde, halogen, carboxylic acid, —NO2, —NH2, —NHCOCH3, and —NH—Y—R′, which is attached directly to AR or attached through an aliphatic chain. The carboxylic acid moiety in R includes but is not limited to the following carboxylic acids: benzoic acids, cinnamic acids, ferulic acid, caffeic acid, syringic acid, salicylic acid, vanillic acid, phenylacetic acids, phenylpropionic acids, and sinapinic acid.-AR—O— is a biologically active phenolic moiety comprising 1 to 6 substituted or unsubstituted aryl rings that are directly bonded to each other, fused together, or joined through a linking group.Y represents a member selected from:—COCH2O— (glycolic ester moiety)—COCH(CH3)O— (lactic ester moiety)—COCH2OCH2CH2O— (dioxanone ester moiety)—COCH2CH2CH2CH2CH2O— (caprolactone ester moiety)—CO(CH2)mO— where m is an integer between 2-4 and 6-24 inclusive—COCH2O(CH2CH2O)n— where n is an integer between 2 and 24, inclusive; andR′ is either hydrogen or a benzyl or an alkyl group, the alkyl group being either straight-chained or branched.The resultant functionalized phenolic compounds, used singly or in combinations, and their polymers have controllable degradation profiles, releasing the active component over a desired time range. The polymers are useful for biomaterials and biomedical devices, wherein said biologically active phenolic moiety is a residue of a phenolic compound.

A Tropaeolum majus effervescent tablet consisting of Tropaeolum majus powder, coixol, syringic acid, sorbitol, xanthan gum, sodium citrate, and sodium bicarbonate. The different components of the Tropaeolum majus effervescent tablet coordinate and achieve the effects of clearing heat, activating blood, resolving stasis, removing toxin and inflammation, and relieving pain. The present invention has treatment effects on idiopathic pulmonary fibrosis and reduces the suffering of idiopathic pulmonary fibrosis patients.